MANUFACTURING / JAPAN SOURCING

Medical device component prototypes: specify the use and the records

A material report, a supplier’s quality-system certificate and evidence for a finished medical device answer different questions. Keep the prototype’s drawing, supplied state and intended evaluation connected.

Tell the supplier what this prototype will be used to learn

Imagine ordering a small machined sleeve for a medical device assembly. The drawing defines the geometry, but the buyer has not said whether the samples are for a bench fit check, a manufacturing trial or evaluation of the finished device. These are fictional circumstances. The supplier needs to know the planned evaluation, what state to supply and which records must remain with the samples.

Identify the component and drawing revision, its function in the assembly, sample quantity and destination. Describe any intended direct or indirect body contact, the relevant surfaces and duration as defined by the device team; mark these as unresolved if they are not yet known. Do not infer contact from the material name or the word “medical”.

State whether the order is for a component, a subassembly or a finished device, and who owns the device-level assessment. A “prototype” label alone does not settle the product category or authorize its intended use. The device owner and relevant specialists should resolve those decisions before the samples are used for a purpose they have not assessed.

Read each document against the question it can answer

ISO describes ISO 13485 as a quality management system standard for organizations involved with medical devices and related services.[1] For a supplier certificate, check the named organization, site, activities, validity and relevance to the proposed work. Keep this organizational evidence separate from the drawing-specific sample results and the finished device’s status.

For the United States, FDA explains that establishment registration and device listing do not denote approval, clearance or authorization, and that it does not issue device registration certificates.[4] A registration claim is therefore not a substitute for checking the actual device and intended use through the appropriate responsible team. This distinction does not determine another country’s requirements.

FDA’s biocompatibility explanation focuses on the whole device in its final finished form, including processing and sterilization where applicable, rather than approving individual fabrication materials.[2] Give the device team the actual material and process information it needs to assess the proposed component. Do not turn a material data sheet into a finished-device biological evaluation.

Keep the part identity with the records, then assess the device separately

1Part: link the drawing revision and sample identity
2Records: material, processing and inspection for the supplied state
3Device assessment: review how this component is used in the finished device

The sleeve is a fictional component. Lines link records to the same part; the dashed enclosure marks a separate device-level review. Neither a report nor a sample drawing is shown as approval.

Define the state in which the samples will arrive

For the sleeve, agree which machining, finishing, cleaning and packaging operations are included, and which later operations belong to the buyer or another supplier. If sterilization is relevant, identify its place in the planned evaluation and the responsible process; do not describe the delivered samples as sterile without the agreed supporting basis.

Request traceable material and process information at the level needed by the project. Distinguish a material certificate, dimensional results, surface or cleanliness evidence and any specialist evaluation. The useful deliverable is a sample set whose identity and supplied state can be reconstructed, not a folder of reports without a link to the actual pieces.

Prototype information to agree before placing the order
Area	State in the request	Ask the supplier to return
Purpose and product boundary	Component, subassembly or finished device; evaluation purpose and owner	Assumptions, exclusions and unresolved use information
Drawing and samples	Part, drawing revision, quantity, sample identifiers and features	Individual results tied to the correct samples and revision
Material	Material maker, grade, specification and lot needs; proposed alternatives	Actual material identity, lot references and deviations
Processing and supply state	Machining, finish, cleaning, packaging and later work	Processes completed, subcontracted scope and supplied condition
Contact and evaluation	Device-team contact description and planned assessment	Relevant information available; gaps for specialist review
Changes and acceptance	Approval authority, evidence and permitted sample use	Proposed changes, outstanding work and disposition records

A changed process needs an explicit comparison

Suppose the trial supplier proposes another material source or a different cleaning process. Record the change before repeating the order. The nominal material designation alone does not describe all differences between the earlier samples and the new ones.

FDA’s documentation examples compare formulation, processing, sterilization and geometry, and explain that changes need supporting information.[3] Use the relevant device team’s assessment to decide what comparison or further evidence is needed for the actual project. The examples are not a declaration that two suppliers’ parts are equivalent.

Agree how the supplier notifies changes in material, process, site or subcontracted work and who can accept them. A dimensional pass on a few prototypes does not establish all device-level requirements or production consistency. Retain the sample disposition and remaining work before ordering a production batch.

Send a request the supplier can answer at component level

Send HAM the part function, drawing revision, planned prototype evaluation, destination and the information still missing. We can help organise questions to Japanese component suppliers about the supplied state, records and proposed deviations. Device design, biological evaluation and market requirements remain with the responsible specialists.

For a quotation, distinguish sample manufacture from additional inspection, process documentation and specialist tests. Ask for the evidence available, its limitations and any work requiring another party, so the next decision is based on a defined component rather than an unexplained “medical grade” claim.

Questions to send your supplier

Open supplier questions

Component function and finished assembly:
Order boundary: component, subassembly or finished device:
Drawing revision, material requirement and sample quantity:
Planned prototype evaluation and permitted sample use:
Intended direct/indirect body contact, surfaces and duration, or unresolved items:
Destination and responsible device/quality reviewers:
Required machining, finish, cleaning, packaging and supplied state:
Sterilization relevance and process responsibility, if applicable:
Material identity/lot, process and individual inspection records needed:
Specialist evaluation planned and missing information:
Proposed deviations, material/process/site changes and notification:
Acceptance authority, disposition and remaining production work:
Please separate sample manufacture, documentation, inspection and additional evaluation work.

Save questions ↓

Sources

ISO — ISO 13485:2016 overview
Read the public QMS overview and organizational scope. Not the purchased standard text, a supplier certificate audit or a device authorization assessment.
FDA — Basics of Biocompatibility
Read whole-device/final-form and material-processing scope. US FDA example; no test endpoints, contact classification or country-specific submission route selected.
FDA — Component and Device Documentation Examples
Read component comparisons and process/formulation changes. Generalized FDA documentation examples, not permission to claim identity or omit tests for this component.
FDA — Registered or certified medical devices
Read establishment registration/listing versus authorization and certificate explanation. US-specific distinction; no live registration or product approval checked.